ProfileGDS5822 / ILMN_2447121
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 42% 25% 12% 16% 0% 35% 6% 2% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 118.842
GSM1276600PDAC Late Ablation Control 21625
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.512
GSM1276603PDAC Late Ablation 210.816
GSM1276604PDAC Late Ablation 30.40
GSM1303940PDAC Late Ablation_anti-CTLA4 116.935
GSM1303941PDAC Late Ablation_anti-CTLA4 24.86
GSM1303942PDAC Late Ablation_anti-CTLA4 31.62